Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinal Ganglion Cells | 9 | 2016 | 162 | 1.390 |
Why?
|
| Rod Opsins | 1 | 2014 | 21 | 0.490 |
Why?
|
| T-Box Domain Proteins | 1 | 2014 | 154 | 0.440 |
Why?
|
| Transcription Factor Brn-3B | 6 | 2016 | 24 | 0.310 |
Why?
|
| Retina | 6 | 2008 | 539 | 0.300 |
Why?
|
| Axons | 2 | 2002 | 441 | 0.290 |
Why?
|
| Transcription Factors | 5 | 2002 | 5432 | 0.230 |
Why?
|
| DNA-Binding Proteins | 4 | 2002 | 5000 | 0.190 |
Why?
|
| Cell Differentiation | 6 | 2008 | 4103 | 0.180 |
Why?
|
| Cell Culture Techniques | 1 | 2002 | 573 | 0.170 |
Why?
|
| Gene Transfer Techniques | 1 | 2002 | 804 | 0.170 |
Why?
|
| Cell Polarity | 1 | 2000 | 211 | 0.160 |
Why?
|
| Transcription Factor Brn-3 | 4 | 2002 | 12 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 2 | 2008 | 1581 | 0.150 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2016 | 1503 | 0.150 |
Why?
|
| Homeodomain Proteins | 3 | 2016 | 1119 | 0.140 |
Why?
|
| Strongylocentrotus purpuratus | 1 | 2016 | 12 | 0.140 |
Why?
|
| Mice | 11 | 2016 | 35461 | 0.120 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2019 | 512 | 0.120 |
Why?
|
| Neck Dissection | 1 | 2014 | 294 | 0.110 |
Why?
|
| Neurogenesis | 1 | 2014 | 241 | 0.100 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2014 | 340 | 0.100 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2019 | 1837 | 0.100 |
Why?
|
| Cell Cycle Proteins | 2 | 2019 | 2115 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2008 | 626 | 0.100 |
Why?
|
| Neurites | 2 | 2002 | 70 | 0.090 |
Why?
|
| Cell Survival | 2 | 2014 | 3055 | 0.080 |
Why?
|
| Animals | 12 | 2019 | 61707 | 0.080 |
Why?
|
| Nerve Degeneration | 1 | 2008 | 162 | 0.070 |
Why?
|
| Mice, Transgenic | 4 | 2008 | 4209 | 0.070 |
Why?
|
| Optic Nerve Diseases | 1 | 2008 | 111 | 0.070 |
Why?
|
| Gene Regulatory Networks | 1 | 2008 | 680 | 0.060 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2004 | 71 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 4958 | 0.060 |
Why?
|
| Lymph Nodes | 1 | 2014 | 3070 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2002 | 5658 | 0.050 |
Why?
|
| Vision, Ocular | 1 | 2004 | 135 | 0.050 |
Why?
|
| Eye Proteins | 1 | 2004 | 275 | 0.050 |
Why?
|
| Transcription Factor Brn-3A | 1 | 2002 | 10 | 0.050 |
Why?
|
| Transcription Factor Brn-3C | 1 | 2002 | 6 | 0.050 |
Why?
|
| Culture Techniques | 1 | 2002 | 144 | 0.050 |
Why?
|
| Expressed Sequence Tags | 1 | 2001 | 108 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2002 | 5693 | 0.050 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2001 | 19 | 0.050 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2001 | 64 | 0.050 |
Why?
|
| Qa-SNARE Proteins | 1 | 2001 | 41 | 0.050 |
Why?
|
| POU Domain Factors | 1 | 2000 | 13 | 0.050 |
Why?
|
| Protein Kinase C-alpha | 1 | 2001 | 67 | 0.050 |
Why?
|
| Neurofilament Proteins | 1 | 2000 | 34 | 0.050 |
Why?
|
| Gene Targeting | 1 | 2002 | 314 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2000 | 693 | 0.040 |
Why?
|
| Embryo, Mammalian | 2 | 2016 | 744 | 0.040 |
Why?
|
| G2 Phase Cell Cycle Checkpoints | 1 | 2019 | 78 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 765 | 0.040 |
Why?
|
| Microtubules | 1 | 2000 | 326 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2001 | 406 | 0.040 |
Why?
|
| tau Proteins | 1 | 2000 | 214 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2001 | 650 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2000 | 530 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 1472 | 0.040 |
Why?
|
| Heterografts | 1 | 2019 | 739 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 16640 | 0.030 |
Why?
|
| Mitosis | 1 | 2019 | 680 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2001 | 2472 | 0.030 |
Why?
|
| Drosophila | 1 | 2001 | 909 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2016 | 245 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2019 | 1824 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2001 | 906 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 7038 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 3524 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 2031 | 0.030 |
Why?
|
| Female | 4 | 2019 | 148487 | 0.030 |
Why?
|
| Neoplasms | 1 | 2019 | 15900 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2019 | 4329 | 0.020 |
Why?
|
| Male | 3 | 2014 | 127915 | 0.020 |
Why?
|
| DNA Damage | 1 | 2019 | 1981 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2001 | 2926 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2001 | 5137 | 0.020 |
Why?
|
| Gliosis | 1 | 2008 | 44 | 0.020 |
Why?
|
| Diphtheria Toxin | 1 | 2008 | 83 | 0.020 |
Why?
|
| Neoplasm, Residual | 1 | 2014 | 1742 | 0.020 |
Why?
|
| Optic Nerve | 1 | 2008 | 139 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2019 | 7230 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2008 | 1039 | 0.020 |
Why?
|
| Cell Death | 1 | 2008 | 684 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 2014 | 2122 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 12953 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 7632 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2019 | 12083 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2008 | 875 | 0.020 |
Why?
|
| Histological Techniques | 1 | 2004 | 62 | 0.010 |
Why?
|
| Visual Acuity | 1 | 2008 | 861 | 0.010 |
Why?
|
| Electroretinography | 1 | 2004 | 126 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 14824 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2008 | 1472 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2008 | 1305 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2004 | 651 | 0.010 |
Why?
|
| Carcinoma | 1 | 2014 | 2607 | 0.010 |
Why?
|
| GAP-43 Protein | 1 | 2001 | 12 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 10258 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2014 | 9464 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 5062 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2001 | 936 | 0.010 |
Why?
|
| Humans | 4 | 2019 | 270026 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 13378 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1999 | 271 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1999 | 227 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 1999 | 213 | 0.010 |
Why?
|
| Disease Progression | 1 | 2008 | 6840 | 0.010 |
Why?
|
| Homozygote | 1 | 1999 | 772 | 0.010 |
Why?
|
| Heterozygote | 1 | 1999 | 1055 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 7342 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 3336 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 33692 | 0.010 |
Why?
|
| Alleles | 1 | 1999 | 2590 | 0.010 |
Why?
|
| Cell Movement | 1 | 1999 | 2457 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 81692 | 0.000 |
Why?
|
| Middle Aged | 1 | 2014 | 90031 | 0.000 |
Why?
|
| Apoptosis | 1 | 1999 | 7740 | 0.000 |
Why?
|